- Home
- ADPT vs YALA Comparison
ADPT vs YALA Comparison
Compare ADPT & YALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- YALA
- Stock Information
- Founded
- ADPT 2009
- YALA 2016
- Country
- ADPT United States
- YALA United Arab Emirates
- Employees
- ADPT 709
- YALA N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- YALA Computer Software: Programming Data Processing
- Sector
- ADPT Health Care
- YALA Technology
- Exchange
- ADPT Nasdaq
- YALA Nasdaq
- Market Cap
- ADPT 749.7M
- YALA 645.8M
- IPO Year
- ADPT 2019
- YALA 2020
- Fundamental
- Price
- ADPT $5.08
- YALA $4.40
- Analyst Decision
- ADPT Buy
- YALA
- Analyst Count
- ADPT 4
- YALA 0
- Target Price
- ADPT $6.50
- YALA N/A
- AVG Volume (30 Days)
- ADPT 1.1M
- YALA 197.1K
- Earning Date
- ADPT 11-07-2024
- YALA 11-11-2024
- Dividend Yield
- ADPT N/A
- YALA N/A
- EPS Growth
- ADPT N/A
- YALA 31.83
- EPS
- ADPT N/A
- YALA 0.74
- Revenue
- ADPT $177,282,000.00
- YALA $329,773,319.00
- Revenue This Year
- ADPT $3.82
- YALA $4.54
- Revenue Next Year
- ADPT $20.38
- YALA $13.09
- P/E Ratio
- ADPT N/A
- YALA $5.95
- Revenue Growth
- ADPT N/A
- YALA 5.34
- 52 Week Low
- ADPT $2.28
- YALA $3.71
- 52 Week High
- ADPT $6.70
- YALA $6.44
- Technical
- Relative Strength Index (RSI)
- ADPT 47.04
- YALA 55.37
- Support Level
- ADPT $5.09
- YALA $4.04
- Resistance Level
- ADPT $6.70
- YALA $4.51
- Average True Range (ATR)
- ADPT 0.46
- YALA 0.16
- MACD
- ADPT 0.00
- YALA 0.03
- Stochastic Oscillator
- ADPT 24.48
- YALA 75.83
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About YALA Yalla Group Limited each representing one
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions.